New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports

Abstract Background Escherichia coli has appeared as an important opportunistic pathogen responsible for nosocomial infections in patients with immunodeficiency, particularly in leukemia patients. New Delhi metallo-beta-lactamase is an enzyme originally found in Enterobacteriaceae. Case presentation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mahdane Roshani, Alireza Goodarzi, Sanaz Dehbashi, Farhad Afrasiabi, Hossein Goudarzi, Ali Hashemi, Mohammad Reza Arabestani
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/b721fadf8fe244c7b0715b378308f370
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b721fadf8fe244c7b0715b378308f370
record_format dspace
spelling oai:doaj.org-article:b721fadf8fe244c7b0715b378308f3702021-11-28T12:37:22ZNew Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports10.1186/s13256-021-03160-21752-1947https://doaj.org/article/b721fadf8fe244c7b0715b378308f3702021-11-01T00:00:00Zhttps://doi.org/10.1186/s13256-021-03160-2https://doaj.org/toc/1752-1947Abstract Background Escherichia coli has appeared as an important opportunistic pathogen responsible for nosocomial infections in patients with immunodeficiency, particularly in leukemia patients. New Delhi metallo-beta-lactamase is an enzyme originally found in Enterobacteriaceae. Case presentation In this study, 80 isolates of Escherichia coli and Klebsiella pneumoniae were collected over the course of 2 years from two medical centers in Tehran, Iran. Production of carbapenemase was detected in the isolates using modified Hodge test. New Delhi metallo-beta-lactamase-1 genes were detected by polymerase chain reaction amplification with specific primers. Two New Delhi metallo-beta-lactamase-1-producing Escherichia coli strains were isolated from two Iranian patients with leukemia. These two patients were 6 and 15 years old, one female and the other male, from two oncology centers in Iran. The isolates were resistant to carbapenems (imipenem, meropenem), and two isolates were positive for carbapenemase production by modified Hodge test. Conclusions The emergence of New Delhi metallo-beta-lactamase-1-producing Escherichia coli is a threat for leukemia patients in oncology and hematology departments. We conclude that the incidence of multidrug resistant pathogens has increased among patients with leukemia and is life threatening.Mahdane RoshaniAlireza GoodarziSanaz DehbashiFarhad AfrasiabiHossein GoudarziAli HashemiMohammad Reza ArabestaniBMCarticlebla NDM-1Escherichia coliKlebsiella pneumoniaeLeukemiaMedicineRENJournal of Medical Case Reports, Vol 15, Iss 1, Pp 1-4 (2021)
institution DOAJ
collection DOAJ
language EN
topic bla NDM-1
Escherichia coli
Klebsiella pneumoniae
Leukemia
Medicine
R
spellingShingle bla NDM-1
Escherichia coli
Klebsiella pneumoniae
Leukemia
Medicine
R
Mahdane Roshani
Alireza Goodarzi
Sanaz Dehbashi
Farhad Afrasiabi
Hossein Goudarzi
Ali Hashemi
Mohammad Reza Arabestani
New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
description Abstract Background Escherichia coli has appeared as an important opportunistic pathogen responsible for nosocomial infections in patients with immunodeficiency, particularly in leukemia patients. New Delhi metallo-beta-lactamase is an enzyme originally found in Enterobacteriaceae. Case presentation In this study, 80 isolates of Escherichia coli and Klebsiella pneumoniae were collected over the course of 2 years from two medical centers in Tehran, Iran. Production of carbapenemase was detected in the isolates using modified Hodge test. New Delhi metallo-beta-lactamase-1 genes were detected by polymerase chain reaction amplification with specific primers. Two New Delhi metallo-beta-lactamase-1-producing Escherichia coli strains were isolated from two Iranian patients with leukemia. These two patients were 6 and 15 years old, one female and the other male, from two oncology centers in Iran. The isolates were resistant to carbapenems (imipenem, meropenem), and two isolates were positive for carbapenemase production by modified Hodge test. Conclusions The emergence of New Delhi metallo-beta-lactamase-1-producing Escherichia coli is a threat for leukemia patients in oncology and hematology departments. We conclude that the incidence of multidrug resistant pathogens has increased among patients with leukemia and is life threatening.
format article
author Mahdane Roshani
Alireza Goodarzi
Sanaz Dehbashi
Farhad Afrasiabi
Hossein Goudarzi
Ali Hashemi
Mohammad Reza Arabestani
author_facet Mahdane Roshani
Alireza Goodarzi
Sanaz Dehbashi
Farhad Afrasiabi
Hossein Goudarzi
Ali Hashemi
Mohammad Reza Arabestani
author_sort Mahdane Roshani
title New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
title_short New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
title_full New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
title_fullStr New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
title_full_unstemmed New Delhi metallo-β-lactamase-1 among Escherichia coli strains isolated from leukemia patients in Iran: two case reports
title_sort new delhi metallo-β-lactamase-1 among escherichia coli strains isolated from leukemia patients in iran: two case reports
publisher BMC
publishDate 2021
url https://doaj.org/article/b721fadf8fe244c7b0715b378308f370
work_keys_str_mv AT mahdaneroshani newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT alirezagoodarzi newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT sanazdehbashi newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT farhadafrasiabi newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT hosseingoudarzi newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT alihashemi newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
AT mohammadrezaarabestani newdelhimetalloblactamase1amongescherichiacolistrainsisolatedfromleukemiapatientsinirantwocasereports
_version_ 1718407914686775296